Cargando…

Mechanisms of the “No-Reflow” Phenomenon After Acute Myocardial Infarction: Potential Role of Pericytes

Pericytes contract during myocardial ischemia resulting in capillary constriction and no reflow. Reversing pericyte contraction pharmacologically reduces no reflow and infarct size. These findings open up an entire new venue of research aimed at altering pericyte function in myocardial ischemia and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaul, Sanjiv, Methner, Carmen, Cao, Zhiping, Mishra, Anusha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	State-of-the-Art Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998747/ https://www.ncbi.nlm.nih.gov/pubmed/36908667 http://dx.doi.org/10.1016/j.jacbts.2022.06.008

Ejemplares similares

No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction
por: Gupta, Sanjiv, et al.
Publicado: (2016)

Intravascular Ultrasound Observation of the Mechanism of No-Reflow Phenomenon in Acute Myocardial Infarction
por: Li, Junxia, et al.
Publicado: (2015)

Therapeutic Genome Editing in Cardiovascular Diseases
por: German, David M., et al.
Publicado: (2019)

Assessment and Treatment of Patients With Type 2 Myocardial Infarction and Acute Nonischemic Myocardial Injury
por: DeFilippis, Andrew P., et al.
Publicado: (2019)

2021 Korean Society of Myocardial Infarction Expert Consensus Document on Revascularization for Acute Myocardial Infarction
por: Chang, Kiyuk, et al.
Publicado: (2021)

No-reflow phenomenon and in vivo cholesterol crystals combined with lipid core in acute myocardial infarction()
por: Katayama, Yosuke, et al.
Publicado: (2022)

Capillary pericytes mediate coronary no-reflow after myocardial ischaemia
por: O'Farrell, Fergus M, et al.
Publicado: (2017)

Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease
por: Franczyk-Skóra, Beata, et al.
Publicado: (2013)

No-reflow phenomenon in acute myocardial infarction: Relieve pressure from the procedure and focus attention to the patient
por: Buono, Andrea, et al.
Publicado: (2019)

Mitochondrial Membrane Permeability Inhibitors in Acute Myocardial Infarction: Still Awaiting Translation
por: Trankle, Cory, et al.
Publicado: (2016)

Comparison of no-reflow phenomenon after percutaneous coronary intervention for acute myocardial infarction between smokers and nonsmokers
por: Shemirani, Hassan, et al.
Publicado: (2014)

Pathophysiology of streptokinase-induced hypotension in acute myocardial infarction: a systematic review of clinical evidence
por: Khalid, Karniza, et al.
Publicado: (2021)

Identifying and Solving Gaps in Pre- and In-Hospital Acute Myocardial Infarction Care in Asia-Pacific Countries
por: Tern, Paul Jie Wen, et al.
Publicado: (2023)

The role of SCUBE1 in the pathogenesis of no-reflow phenomenon presenting with ST segment elevation myocardial infarction
por: Bolayır, Hasan Ata, et al.
Publicado: (2017)

Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies
por: Frantz, Stefan, et al.
Publicado: (2022)

Designing Acellular Injectable Biomaterial Therapeutics for Treating Myocardial Infarction and Peripheral Artery Disease
por: Hernandez, Melissa J., et al.
Publicado: (2017)

Botulinum toxin A in the treatment of Raynaud's phenomenon: a systematic review
por: Żebryk, Paweł, et al.
Publicado: (2015)

No-Reflow Phoenomenon by Intracoronary Thrombus in Acute Myocardial Infarction
por: Lim, Sang Yup
Publicado: (2016)

Effects of no-reflow phenomenon on ventricular systolic synchrony in patients with acute anterior myocardial infarction after percutaneous coronary intervention
por: Wang, Le, et al.
Publicado: (2016)

Intracoronary pressure gradient measurement in acute myocardial infarction patients with the no-reflow phenomenon during primary percutaneous coronary intervention
por: Gao, Ming-Dong, et al.
Publicado: (2020)

No-Reflow Phenomenon and Endothelial Glycocalyx of Microcirculation
por: Maksimenko, Alexander V., et al.
Publicado: (2012)

“No-Reflow” Phenomenon: A Contemporary Review
por: Annibali, Gianmarco, et al.
Publicado: (2022)

Prediction of no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
por: Yang, Li, et al.
Publicado: (2020)

Growth Differentiation Factor 15 as a Predictor of the No-Reflow Phenomenon in Patients with ST-Segment Elevation Myocardial Infarction
por: Kożuch, Marcin, et al.
Publicado: (2022)

Pathophysiology of depression and mechanisms of treatment
por: Brigitta, Bondy
Publicado: (2002)

Mechanisms of cancer-associated thrombosis
por: Hisada, Yohei, et al.
Publicado: (2023)

Association between the No-Reflow Phenomenon and Soluble CD40 Ligand Level in Patients with Acute ST-Segment Elevation Myocardial Infarction
por: Tascanov, Mustafa Begenc, et al.
Publicado: (2019)

The predictors of no reflow phenomenon after percutaneous coronary intervention in patients with ST elevation myocardial infarction: A meta-analysis
por: Fajar, Jonny Karunia, et al.
Publicado: (2018)

Serum cystatin C levels relate to no-reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction
por: Cheng, Chao, et al.
Publicado: (2019)

Platelet/lymphocyte ratio for prediction of no-reflow phenomenon in ST-elevation myocardial infarction managed with primary percutaneous coronary intervention
por: Badran, Hala Mahfouz, et al.
Publicado: (2020)

Impact of Stress Hyperglycemia on No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Khalfallah, Mohamed, et al.
Publicado: (2022)

AMPA receptor trafficking and the mechanisms underlying synaptic plasticity and cognitive aging
por: Henley, Jeremy M., et al.
Publicado: (2013)

Pharmacogenomic Discovery to Function and Mechanism: Breast Cancer as a Case Study
por: Wang, Liewei, et al.
Publicado: (2017)

Exercise-Induced Cardiac Troponin Elevations: From Underlying Mechanisms to Clinical Relevance
por: Aengevaeren, Vincent L., et al.
Publicado: (2021)

Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction
por: Qi, Qi, et al.
Publicado: (2018)

Critical Reanalysis of the Mechanisms Underlying the Cardiorenal Benefits of SGLT2 Inhibitors and Reaffirmation of the Nutrient Deprivation Signaling/Autophagy Hypothesis
por: Packer, Milton
Publicado: (2022)

The Elevated Soluble ST2 Predicts No-Reflow Phenomenon in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Somuncu, Mustafa Umut, et al.
Publicado: (2019)

Impact of the Total Ischemia Time on No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Khalfallah, Mohamed, et al.
Publicado: (2022)

Effects of tirofiban on the reperfusion-related no-reflow in rats with acute myocardial infarction
por: Liu, Xiao, et al.
Publicado: (2013)

Fibroblasts in the Infarcted, Remodeling, and Failing Heart
por: Humeres, Claudio, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1sqebdblhvnak15l1me0hbr3e6